medical device News

The Medical Device's Trademark is Also Registered in the United States, Australia, China, South Korea, Singapore and Switzerland

VIVID IMGING technical service division’s core competencies encompass contrast delivery injectors,MRI coils (RF technology), surgical robotics and diagnostic imaging technologies and systems such as x-ray, ultrasound, imager and CR systems.

Revisions Motivated by New GTIN Standards, U.S. FDA 510(k) Clearance, and Emerging International Demand

Medipurpose Conducted the Survey to Further Validate Its Extensive Research About 28-Gauge Safety Lancet Market Requirements

Agreement Continues U.K. Distribution of SurgiLance Safety Lancets, Now Also Includes babyLance Heel Sticks

Polymedco Updates Website with the Addition of Medical Glossary

Medical device application landscape influenced by the adoption of emerging drug-device combinations

Qualified Submissions to Earn Entry for Amazon Kindle Drawing

Asante Solutions, Inc. a medical device company focused on diabetes care, will be relocating in late November to a new headquarters in Sunnyvale, Calif. Colliers International represented the company in the transaction.

Jon E. Block, Ph.D., Inc., an internationally recognized clinical affairs consulting firm based in San Francisco announced today it has rebranded as The Jon Block Group (www.JonBlockGroup.com).

The medical device company was recently notified that the Intellectual Property Office of Singapore approved MediPurpose’s application to register a trademark, collective mark or certification mark in Singapore for MediPlus.

Polymedco is pleased to announce that we are hiring for several new positions.

Italian Medical Product Distributor is Expanding babyLance’s Global Reach

Strategies and Best Practices in Making the Business Case for Investments in Evolving Technologies from R&D and Workforce Efficiencies to Internal Lifecycle Management through Leveraging Industry Case-Studies and Expert Evaluations

Trial By Fire Solutions today announced that a US-based developer and manufacturer of vascular disease treatments has selected SimpleCTMS to help manage their global clinical program.

Pearl Pathways to Parent Pearl IRB and Two New Sister Companies

Cervilenz Inc. will be presenting this year at AdvaMed 2011 in Washington, DC. to share news on a significant advance in obstetrics and how their new device will help physicians improve pregnancy outcomes.

Sept. 23, 2011, Taipei City, Taiwan – Polysciences, Inc. proudly announces the opening of their new Taiwan office in an effort to expand their global presence.

The rapid discovery of treatments for vascular diseases demands rapid development of device initiatives.

More Than 140 Neonatal Nurses and Educators Entered Daily Drawing

SAN DIEGO, CA -- True Diagnostics, Inc. announces that Dr. Mark Stearns has joined the Company’s Scientific Advisory Board.

Attendees Can Earn Entries by Evaluating the babyLance Heel Incision Device at MediPurpose Booth 436

This course will describe the regulatory and business requirements for Excel spreadsheets, using examples from FDA recommendations. It will then cover the design and installation of those Excel Spreadsheets, to ensure the integrity of the data,

Round Rock, Texas – (August 29, 2011) – Cerilliant Corporation announces certification to ISO 13485:2003, Quality Management System for Medical Devices, adding to its existing accreditations of ISO Guide 34, ISO 17025 and ISO 9001.

Medikus, a Semi-Exclusive Distributor for babyLance in Austria, has Partnered with Medipurpose Since December 2010

Equivalent of U.S. FDA Registration, CA Registration Enables Distribution of babyLance in Italy

This webinar provides step by step instructions on how to design and manage a CAPA system that meets and exceeds compliance requirements

FDA-mandated post-market studies are coming. Phase IV studies are likely to be complex in design and large in scale (possibly 500,000 patients per arm), with exacting endpoints, and obligatory. The FDA appears to be abandoning a long-standing policy

“Environmental Monitoring and Certification in Controlled Environments: Meeting Regulations and Achieving Effective Microbial Control for Pharmaceutical and Medical Device Manufacturers” – New White Paper from Microtest Laboratories

In addition to its trademark for its corporate logo, MediPurpose has also received international patents and trademarks for its medical products: babyLance heel incision devices, SurgiLance safety lancets and MediPlus advanced wound care products.

This webinar will discuss current regulatory and quality requirements for reduced testing of components used in pharmaceuticals and medical devices. Reduced testing will be viewed from current industry practice, the regulations,

"Attendees will recieve a complimentary e-book of " How to write standard operating procedures and work Instructions", published by the Instructor in 2010.The e-book will be send out to attendees after the webinar.

Who will benefit: Quality Control Laboratory Manager Warehousing Purchasing Managers Procurement Managers Laboratory Analyst Cost Accounting

Relationship Extends MediPurpose's Resources for New Medical Product Development

New Distribution Partnership with Haemoclub International SLR Already Reporting Considerable Interest in Italy for MediPurpose’s Fingersticks and Infant Heelsticks

This training will outline practical steps to design medical device software that does not compromise on performance reliability and patient safety, thereby preventing product recalls.

Cervilenz Inc. announced today the addition of a new member to its Board of Directors. Eileen Maus brings 20 years of experience in the life sciences industry as a senior sales and marketing executive.

Phillips will be representing all three of MediPurpose's medical products, which include babyLance infant heel incision device, SurgiLance safety lancets, and MediPlus advanced wound care products.

This webinar will take a look at recent market events to assess the potential long term impact on the medical device sector.

An examination of publicly available FDA data by Emergo Group on 510(k) clearances over the last five years indicates that 80% of devices receive clearance within six months.

Cervilenz Inc. has been selected to present at OneMedForum, a prestigious conference which connects healthcare/life science-focused emerging companies, business development executives, and investors.

The new title reflects Rudnak's expanding responsibilities with the medical product company, which include planning and executing marketing strategies that promote awareness of the company's products and services.

Company honored for assisting more than 1,000 US companies exporting their medical devices overseas.

TechTrade has achieved ISO 13485 certification for its Ready-Heat Disposable Medical Heating Blanket with assistance from Emergo Group.

Launched last July, babyLance is a single-use heel incision device utilized to obtain a blood sample from the heels of newborn (babyLance BLN) and preemie (babyLance BLP) infants.

The medical device company was recently notified that the World Intellectual Property Organization received a Statement of Grant of Protection from the Japan Patent Office, which protects the SurgiLance mark in Japan.

Colorado BioScience Association (CBSA) announces Steve Orndorff, President & CEO of Ariel pharmaceuticals, as the new chairperson of the board of directors. Orndorff assumes chairperson responsibilities from Rick Jory, Sandhill Scientific, Inc.

According to our own study, 98% of medical vendors admit to bypassing hospital vendor check in due to knowingly being non-compliant with that hospitals credentialing requirements. Medical Companies are at incredible risk and they may not even know.

HealthTrust's membership supports nearly 1,400 not-for-profit and for-profit acute care facilities, as well as 10,600 ambulatory surgery centers, physician practices and alternate care sites.

This cGMP webinar for medical device companies will focus on recent manufacturing lapses that have resulted in major recalls, multi-million dollar fines and some criminal charges. It will analyze why they happened and show how to prevent it.